Key Takeaways
- UiPath will release Q2 fiscal 2027 financial results Thursday, September 3, following the closing bell
- Analyst consensus calls for non-GAAP EPS of $0.15 and revenue of $397.85M, approaching the upper end of guidance
- PATH shares have climbed approximately 40% in the last month, currently hovering near $18.15
- Critical performance indicators include ARR progression, net retention figures, and agentic AI traction
- The company has surpassed both earnings and revenue projections in 7 out of its most recent 8 quarterly reports
UiPath (PATH) will unveil its second-quarter fiscal 2027 earnings this Thursday, September 3, following the conclusion of regular trading hours. Shares are currently changing hands around $18.15, reflecting a substantial gain of nearly 40% throughout the past month.
The Street is anticipating non-GAAP earnings per share of $0.15 alongside revenue totaling $397.85M. This revenue forecast positions expectations at the upper boundary of the company’s own projected range of $395M to $400M.
During the previous quarter, UiPath delivered revenue of $418.4M, representing a 17.3% year-over-year increase. Annual Recurring Revenue (ARR) reached $1.901B, climbing 12%, while the dollar-based net retention rate achieved 109%.
The automation software provider also achieved its inaugural quarterly GAAP operating profit of $27.99M in Q1. This represented a significant turning point that captured investor attention.
For the upcoming quarter, Wall Street analysts are projecting revenue expansion of approximately 10% compared to the year-ago period. This would represent a deceleration from the 14.4% growth rate achieved during the comparable quarter last year.
Company leadership has issued Q2 guidance targeting ARR between $1.929B and $1.934B, with non-GAAP operating income projected at approximately $75M. Market participants will be scrutinizing these figures carefully.
UiPath has exceeded both earnings and revenue forecasts in 7 of its previous 8 quarterly reports. This consistent performance record provides optimistic investors with confidence approaching Thursday’s announcement.
Wall Street Remains Divided
Analyst sentiment remains mixed. SA analyst Investing Smart maintains a “Hold” stance, highlighting competitive headwinds, a more modest full-year growth trajectory, and elevated short interest representing approximately one-third of shares available for public trading.
Such substantial short interest creates conditions for significant price volatility following the earnings announcement. This is an important consideration for traders.
Conversely, SA analyst Danil Sereda rates the stock a “Buy,” anticipating UiPath will exceed Q2 revenue projections and achieve its $1.93B ARR target. His thesis emphasizes the company’s strong cash reserves, path to profitability, and positioning within the agentic AI market.
The consensus analyst price target stands at $13.87, representing a discount to the current market price of $18.08. This valuation disconnect warrants investor consideration.
Key Metrics Beyond Headline Figures
While revenue and earnings figures will command attention, they won’t provide the complete picture. Investor focus will center on ARR trajectory, customer retention metrics, and progress in agentic AI implementation.
Company executives have highlighted preliminary indicators of momentum recovery, including an 18% year-over-year expansion in customers contributing over $1M in ARR. This enterprise customer growth metric will face heightened scrutiny.
Competitive threats from Microsoft (MSFT), OpenAI, and emerging AI-native automation platforms continue to represent a strategic challenge. Market participants will seek clarity on management’s defensive and offensive positioning strategy.
For the year-to-date period, PATH has advanced 12.08%, marginally outperforming the S&P 500’s 11.48% return. The stock has gained only approximately 1% over the trailing week, indicating investors are adopting a wait-and-see posture before the earnings release.
Sell-side analysts tracking the company have maintained relatively stable estimates throughout the past 30 days, suggesting expectations for performance broadly aligned with current consensus forecasts.





